VERV
Price
$3.85
Change
-$0.06 (-1.53%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
347.19M
34 days until earnings call
XRTX
Price
$0.96
Change
-$0.00 (-0.00%)
Updated
Apr 3, 04:26 PM (EDT)
Capitalization
3.07M
Ad is loading...

VERV vs XRTX

Header iconVERV vs XRTX Comparison
Open Charts VERV vs XRTXBanner chart's image
Verve Therapeutics
Price$3.85
Change-$0.06 (-1.53%)
Volume$33.02K
Capitalization347.19M
XORTX Therapeutics
Price$0.96
Change-$0.00 (-0.00%)
Volume$322
Capitalization3.07M
VERV vs XRTX Comparison Chart
Loading...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VERV vs. XRTX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VERV is a Hold and XRTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (VERV: $3.91 vs. XRTX: $0.96)
Brand notoriety: VERV and XRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VERV: 193% vs. XRTX: 23%
Market capitalization -- VERV: $341.86M vs. XRTX: $3.07M
VERV [@Biotechnology] is valued at $341.86M. XRTX’s [@Biotechnology] market capitalization is $3.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VERV’s FA Score shows that 1 FA rating(s) are green whileXRTX’s FA Score has 0 green FA rating(s).

  • VERV’s FA Score: 1 green, 4 red.
  • XRTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both VERV and XRTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VERV’s TA Score shows that 4 TA indicator(s) are bullish while XRTX’s TA Score has 5 bullish TA indicator(s).

  • VERV’s TA Score: 4 bullish, 4 bearish.
  • XRTX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, XRTX is a better buy in the short-term than VERV.

Price Growth

VERV (@Biotechnology) experienced а -27.59% price change this week, while XRTX (@Biotechnology) price change was +1.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

VERV is expected to report earnings on May 07, 2025.

XRTX is expected to report earnings on May 01, 2024.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERV($347M) has a higher market cap than XRTX($3.07M). XRTX YTD gains are higher at: -15.014 vs. VERV (-30.674). XRTX has higher annual earnings (EBITDA): -4.33M vs. VERV (-221.91M). VERV has more cash in the bank: 524M vs. XRTX (2.3M). XRTX has less debt than VERV: XRTX (61.5K) vs VERV (70M). VERV has higher revenues than XRTX: VERV (32.3M) vs XRTX (0).
VERVXRTXVERV / XRTX
Capitalization347M3.07M11,307%
EBITDA-221.91M-4.33M5,131%
Gain YTD-30.674-15.014204%
P/E RatioN/A8.00-
Revenue32.3M0-
Total Cash524M2.3M22,773%
Total Debt70M61.5K113,821%
FUNDAMENTALS RATINGS
XRTX: Fundamental Ratings
XRTX
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
75
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
VERVXRTX
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 10 days ago
87%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 7 days ago
90%
View a ticker or compare two or three
Ad is loading...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRSRX48.83N/A
N/A
Putnam Research R
SSEAX11.56N/A
N/A
SEI Screened World Equity Ex-US A (SIIT)
NUGIX33.82N/A
N/A
Nuveen Global Dividend Growth I
TRGLX61.09N/A
N/A
T. Rowe Price Global Stock I
QCLVX31.55N/A
N/A
Federated Hermes MDT Large Cap Value C

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with CRSP. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
-5.44%
CRSP - VERV
54%
Loosely correlated
+3.17%
BEAM - VERV
53%
Loosely correlated
+4.79%
RXRX - VERV
50%
Loosely correlated
+3.83%
NTLA - VERV
48%
Loosely correlated
+9.69%
IVEVF - VERV
46%
Loosely correlated
N/A
More

XRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, XRTX has been loosely correlated with BCDA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if XRTX jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRTX
1D Price
Change %
XRTX100%
+6.31%
BCDA - XRTX
44%
Loosely correlated
+6.07%
VERV - XRTX
43%
Loosely correlated
-5.44%
SPHDF - XRTX
32%
Poorly correlated
N/A
TRML - XRTX
31%
Poorly correlated
-5.90%
BYSI - XRTX
26%
Poorly correlated
-3.09%
More